MARATTO

article · African Journal of Primary Health Care & Family Medicine

Oral iron supplementation as a public health intervention in children aged 6 to 23 months for preventing iron deficiency and anaemia: Economic evaluation for the South African health system

Abstract

BACKGROUND: Anaemia prevalence among Southern African children aged 6-23 months was estimated at 65% in 2019. The World Health Organization recommends that children aged 6-23 months living in countries with an anaemia prevalence above 40% should receive preventive oral iron supplements. AIM: This study aimed to conduct a context-specific economic evaluation of oral iron supplementation in children aged 6 months - 23 months for preventing iron deficiency and anaemia in South Africa (SA). METHOD: We undertook a cost-effectiveness analysis (CEA), comparing preventive iron supplementation with no supplementation. Using a 1-year time horizon, we took a provider perspective and used circulating haemoglobin as the effectiveness outcome. The incremental cost-effectiveness ratio (ICER) was calculated as the cost per disability-adjusted life year (DALY) because of anaemia averted. A budget impact analysis (BIA) was carried out to estimate start-up and total annual costs of intervention implementation in SA. RESULTS: The ICER (cost per DALY averted) was R1077.00 ($58.40); below a conservative context-relevant threshold (R62 916.00 [$3410.00]) (2024). Budget impact analysis estimated total costs over 2 years (2024-2025), excluding start-up costs, of R16.94 ($0.92) per child aged 2 years in SA, based on the CEA dosing regimen. Intervention costs (including start-up costs) represent 0.007% of the total health budget (2024). CONCLUSION: Preventive oral iron supplementation resulted in increased effectiveness for averting DALYs because of anaemia. Comparisons of the ICER with context-relevant thresholds suggested the intervention could be considered cost-effective in SA.Contribution: Our findings of potential cost-effectiveness and budget impact could be used to inform decision-making for primary healthcare resource allocation in SA's health system.

Research topics

  • Iron Metabolism and Disorders
  • Hemoglobinopathies and Related Disorders
  • Erythropoietin and Anemia Treatment

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.4102/phcfm.v18i1.5083

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.